PROF
Profound Medical Corp.
NASDAQ · Healthcare · Medical - Devices · CA
$6.89
+1.32%Sep 3, 2026, 11:11 UTC
Profound Medical Corp. announced a role change for Mathieu Burtnyk to Chief Technology Officer, effective September 1, 2026.
Sep 1, 2026, 12:00 UTC
Profound Medical Corp. appointed Richard Fabian as its new President, effective immediately.
Source:Aug 17, 2026, 12:30 UTC
Profound introduced new real-time interventional MRI software (TDC) that enables customers to perform up to 6 TULSA Procedures per system per day.
Source:Aug 17, 2026, 00:00 UTC
Profound Medical Corp. announced that Rashed Dewan resigned as Chief Financial Officer, effective August 14, 2026, and appointed Matthew Sobczyk as Interim Chief Financial Officer.
Aug 14, 2026, 20:30 UTC
Profound Medical Corp. promoted Matthew Sobczyk from Corporate Controller to Interim Chief Financial Officer, effective immediately, succeeding Rashed Dewan who stepped down as CFO.
Source:Aug 7, 2026, 03:36 UTC
Profound Medical reported Q2 2026 earnings of $0.26 per share, beating the Zacks Consensus Estimate of a loss of $0.22 per share, and compared to a loss of $0.52 per share a year ago.
Source: